Intrinsic Value of S&P & Nasdaq Contact Us

Strongbridge Biopharma plc SBBP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Strongbridge Biopharma plc (SBBP) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 9 Buy, 2 Hold.

SBBP Analyst Ratings

Buy
11
Ratings
9 Buy
2 Hold
Based on 11 analysts giving stock ratings to Strongbridge Biopharma plc in the past 3 months
Rating breakdown
Buy
9 82%
Hold
2 18%
82%
Buy
9 analysts
18%
Hold
2 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message